There is increasing evidence of activity-related plasticity in auditory pathways. The present study examined the effects of decreased activity on immunolocalization of the inhibitory neurotransmitter glycine in the cochlear nucleus of the rat after bilateral cochlear ablation. Specifically, glycine-immunoreactive puncta adjacent to somatic profiles were compared in normal hearing animals and animals deafened for 14 days. The number of glycine-immunoreactive puncta surrounding somatic profiles of spherical and globular bushy cells, glycineimmunoreactive type I stellate multipolar cells, radiate neurons (type II stellate multipolar cells), and fusiform cells decreased significantly. In addition, the number of glycine immunopositive tuberculoventral (vertical or corn) cells in the deep layer of the dorsal cochlear nucleus also decreased significantly. These results suggest that decreased inhibition reported in cochlear nucleus after deafness may be due to decreases in glycine. V V C 2005 Wiley-Liss, Inc.
There is increasing evidence of plasticity in the mature auditory system, with decreased activity from deafness or increased activity from noise overstimulation capable of inducing marked changes (recently reviewed by Syka, 2002) . Activity-induced changes in the auditory brain stem range from changes in gene expression (e.g., Holt et al., 2005) to changes in neuronal response profiles (Francis and Manis, 2000) . One of the most striking deafness-related changes in the auditory brain stem is a decrease in inhibition and an increase in spontaneous or evoked excitation, found in both the inferior colliculus (IC) and the cochlear nucleus (CN; Gerken, 1979; Willott and Lu, 1982; Bledsoe et al., 1995; Kaltenbach, 2000; Mossop et al., 2000; Salvi et al., 2000; Willott and Turner, 2000; Shaddock Palombi et al., 2001) , often leading to a change in the tonotopic map Nagase et al., 2000; Snyder et al., 2000) . In the IC, the decreased inhibition seems associated with decreases in the inhibitory amino acid neurotransmitter g-aminobutyric acid (GABA), with studies showing decreased GABA release (Bledsoe et al., 1995) and decreases in the GABAsynthesizing enzyme glutamic acid decarboxylase (GAD) as well as GABA binding (Bauer et al., 2000; Milbrandt et al., 2000; Mossop et al., 2000; Caspary et al., 2002) . In the CN, however, many studies suggest that glycine is the major inhibitory transmitter (Altschuler et al., 1986; Wu and Oertel, 1986; Caspary et al., 1987 Caspary et al., , 1994 Wenthold et al., 1987; Adams and Mugnaini, 1990; Bledsoe et al., 1990; Wickesberg and Oertel, 1990; Helfert et al., 1992; Kolston et al., 1992; Zook, 1992, 1999; Grothe and Sanes, 1993; Wickesberg et al., 1994; Wu and Kelly, 1994; Sato et al., 1995; Golding and Oertel, 1996; Juiz et al., 1996; Harty and Manis, 1998; Doucet et al., 1999; Godfrey et al., 2000; Zheng et al., 2000) . Decreases in glycine-immunoreactive neurons and puncta (Willott et al., 1993; Willott and Turner, 2000) and changes in glycine receptor subunits (Krenning et al., 1998) are associated with age-related hearing loss. Glycine release, glycine uptake, and glycine receptor binding all change after cochlear ablation (Suneja et al., 1998a,b; Potashner et al., 2000) . Because glycine is implicated in deafness-related decreases in inhibition within the CN, then decreased glycine levels might also be expected in the CN. We therefore addressed whether there are deafness-related decreases in glycine immunoreactivity within the cochlear nucleus 14 days after deafness. The 14-day point after deafness was chosen because marked decreases in the release of GABA have been observed in the inferior colliculus at this time after deafness (Bledsoe et al., 1995 (Bledsoe et al., , 1997 .
MATERIALS AND METHODS

Animals and Surgical procedures
All animals used in this study were female SpragueDawley rats weighing between 200-300 g and were obtained from Charles River Laboratories. The experimental group of rats was bilaterally deafened via introduction of neomycin through each round window. This deafened group (n ¼ 5) was assessed 14 days after deafening. The animals in the control group (n ¼ 5) were age matched and had normal hearing based on auditory brain stem response (ABR) measures. Each rat in the deafened group was anesthetized with intramuscular injections of xylazine (8 mg/kg) and ketamine (75 mg/kg). Local injections of 1% lidocaine-HCl solution were also made at the site of each surgical incision (subcutaneous). Surgical procedures were carried out under aseptic conditions. The skin incision was made through the postauricular region of the lateral neck. The bulla was exposed without resection of any major muscles. A small defect in the bulla was opened and 30 ml of 30% neomycin were injected over 3 min through the round window using a Hamilton syringe. The skin incision was then closed with sutures. After surgery, animal were injected with sterile 0.9% sodium chloride solution and allowed to recover under a heating lamp.
Hearing Loss Assessment
Hearing was assessed by auditory brain stem response (ABR) measures at 2, 10, and 20 kHz in all animals at the beginning of the study and only those with normal hearing were included in the study. A second measure of hearing was done 14 days after the deafening, for animals in the deafness group. An 80-dB shift from the normal control threshold averaged across the three frequencies was considered necessary for continued inclusion in the deafness group.
Tissue Processing
All rats were deeply anesthetized with a single intraperitoneal dose of 350 mg/kg of chloral hydrate and then perfused transcardially with 30 ml of 0.12 M phosphate buffered saline (PBS; pH 7.4), followed immediately by 300 ml mixed aldehyde fixative containing 2% paraformaldehyde and 1.25% glutaraldehyde in 0.12 M phosphate buffer. Animals were decapitated and brains were carefully removed from the cranium and then immersed in the same fixative for 90 min at 48C for post fixation. After an 8-14-hr rinse in PBS, the lower brain stem (medulla and pons) was dissected and glued onto a chuck. Coronal sections (150 mm) containing the CN were cut with a vibrating microtome (Vibratome). Slices were chosen that contained a predefined (based on anatomic landmarks and cytoarchitectural features), consistent, region of interest (ROI) in the anteroventral cochlear nucleus (AVCN), posteroventral cochlear nucleus (PVCN), or the dorsal cochlear nucleus (DCN). These sections were placed in 1% OsO 4 in phosphate buffer for 45 min. This was followed by a rinse in phosphate buffer, incubation for 1 hr in 2% uranyl acetate, and another phosphate buffer rinse. Sections were then dehydrated through a graded series of ethanol and then infiltrated through graded mixtures of EPON 812 and propylene oxide. After 4 hr in 100% EPON 812, sections were placed between plastic sheets and polymerized for 48 hr at 608C. Sections were viewed under a Leica dissecting microscope. For each animal assessed, an area containing the ROIs (AVCN, PVCN, and DCN) was cut out of the specific sections in which they were present and glued onto an ultramicrotome chuck. Serial 1-mm semithin sections were then cut through the ROI on a Reichert ultramicrotome. Systematic random sampling (Coggeshall and Lekan, 1996) was utilized, where the starting point for a series were random with the next sections in the series and then assessed at fixed intervals. Five 1-mm sections (separated by 12 mm; the 1st, 13th, 25th, 37th, and 49th in each series once the start point was selected) from each rat were processed for immunocytochemistry and quantitative analysis. Five adjacent 1-mm sections (the 2nd, 14th, 26th, 39th and 50th in the series) received a Nissl stain (toluidine blue) for anatomic reference.
Immunocytochemistry
Sections were etched for 40 min in sodium ethoxide, rehydrated, and then treated in 1% sodium periodate for 10 min. Postembedding immunocytochemistry was then carried out. Sections were incubated 48C for 40 hr in rabbit anti-glycine antibody IgG (Chemicon, Temecula, CA) diluted 1:1,200 in 0.5 M Tris buffer containing 5.0% normal goat serum. After thorough rinsing in Tris buffer, sequential incubations were carried out after using the Vectastain procedure (biotinylated goat anti-rabbit IgG diluted 1:100 in 0.5 M Tris buffer containing 5.0% normal goat serum; avidin-biotin-peroxidase complex [ABC Kit], diluted in 0.5 M Tris buffer). Sections were then treated for 3 min in 0.05% diaminobenzidine (DAB) in 0.01% H 2 O 2 to visualize the reaction product. The DAB reaction was then stopped rapidly by rinsing several times with double-distilled water. Sections were then dried, dehydrated, and coverslipped.
Image Acquisition
Five sections each from five rats in each group were used for AVCN, PVCN, and DCN assessments. Digital images were acquired with a Spot camera (Diagnostic Instruments, Inc.) on a Zeiss Axioscop2 photomicroscope and assessed quantitatively using MetaMorph (Universal Imaging) software. A grayscale image from each ROI on a section was acquired using the CCD camera while holding all image-gathering parameters constant. Cells types were differentiated based on the size, shape, and location criteria of Cant and Morest (Cant and Morest, 1979a,b; Cant, 1981) as well as glycine-immunoreactive staining. A somatic profile of a neuron needed to contain a nucleus to be assessed. Because nuclei are no larger than the 12-mm interval between sections, this ensured that the same neuron would be not assessed twice. Every neuron with an identifiable nucleus was assessed within each predefined ROI. The somatic profile of each neuron with a nucleus was circled and the area, perimeter, and shape of the neurons were entered automatically into a spreadsheet program. Positive immunostaining was defined as intensity at least 7Â over background and positive puncta were defined further by size constraints (1.0-4.5 mm 2 ) and shape (round to oval) criteria. The number of glycineimmunoreactive puncta directly apposing each circled somatic profile was then determined and entered into the spreadsheet program. Additionally, the number of immunopositive tuberculoventral cells within the deep layer of the DCN was also determined in DCN sections.
Statistical Analyses
Analysis of variance (ANOVA) was carried out using StatView software. Comparison between normal hearing and deafened groups was made for axosomatic puncta and for the cell area for each cell type from each of 25 sections assessed in each group. The average was calculated per animal, with degrees of freedom (df) equal to 1 in the numerator (deaf vs. normal) and 8 in the denominator (five animals per group) with a confidence level of 95% necessary for significance. A Scheffe multiple comparison test was used for post-hoc comparisons.
RESULTS
Glycine Immunoreactivity: Normal
Glycine-immunoreactive staining in the CN of normal hearing rats ( Fig. 1 and 2 ) was consistent with the results of previous studies (Altschuler et al., 1986; Wenthold, 1987; Wenthold et al., 1987; Wickesberg and Oertel, 1990; Kolston et al., 1992; Wickesberg et al., 1994; Juiz et al., 1996; Doucet et al., 1999) . Most neurons in the VCN were not immunostained for glycine; however, glycine-immunoreactive radiate neurons (type II stellate multipolar cells; Doucet and Ryugo, 1997; Doucet et al., 1999) and smaller glycine-immunoreactive type I stellate multipolar cells were found throughout the magnocellular area of the VCN. Almost all neurons in the magnocellular region of the VCN had glycine-immunoreactive puncta on their somata. These ranged from few on the soma of type I stellate multipolar cells to numerous on the soma of spherical and globular bushy cells. In the DCN (Fig. 1) , many glycineimmunostained cells were found in the molecular layer and glycine-immunostained tuberculoventral (vertical, corn) cells (Wickesberg et al., 1991 (Wickesberg et al., , 1994 were in the deep layer. Numerous glycine-immunoreactive axosomatic puncta were found on fusiform cells of the fusiform layer.
Deafness-Related Changes in CN
Because there was also a decrease in the area of somatic profiles for most CN cell types after deafness, an increase in the density of glycine-immunostained axosomatic puncta could theoretically result as the area they could contact shrinks, with an ''artificial'' increase in their number per somatic profile. The present study, however, found marked decreases after deafening in the number of glycine-immunostained axosomatic puncta considered either as the total per somatic profile or the number per 10 mm of somatic profile. Whatever effect the change in cell size might have had was overcome by the magnitude of the decrease in labeled puncta. There was also a decrease in the number of glycine-immunostained tuberculoventral cells in the deep layer of the DCN.
Spherical bushy cells. Spherical bushy cells (normal, n ¼ 145; deaf, n ¼ 199) were located in the AVCN and were not immunostained for glycine. They were spherical in shape, large (>250 mm 2 ), and received large numbers (>20) of glycine-immunopositive axosomatic puncta on a somatic profile. The number of axosomatic glycine-immunoreactive puncta per somatic profile for spherical bushy cells was 39.5 6 4.9 in normal hearing animals. In animals that were deaf for 14 days, there was a significant (P 0.01) 59% decrease to 12.1 6 5.0 ( Fig. 2  and 3 ). The decrease was 53% (significant, P 0.01) when expressed as the number of puncta per 10 mm of somatic profile, going from 13.0 6 2.2 in normal hearing animals to 6.2 6 2.6 after deafening (Fig. 3 ). Spherical bushy cells had an average area of 347.9 6 66.9 mm 2 in the AVCN of normal hearing animals. Fourteen days after deafness there was a significant (P 0.01) 21% decrease in average area to 274.3 6 67.9 mm 2 (Fig. 4) , comparable to what has been described previously Rubel, 1989, 1991; Pasic et al., 1994; Lesperance et al., 1995; Winsky and Jacobowitz, 1995; Nishiyama et al., 2000) .
Globular bushy cells. Globular bushy cells were located in the PVCN (Fig. 2A,B) and were not immunostained for glycine (normal, n ¼ 165; deaf, n ¼ 235). They were spherical in shape, large (>250 mm 2 ) and received large numbers (>20) of glycine-immunopositive axosomatic puncta on a somatic profile. The number of axosomatic glycine-immunoreactive puncta per somatic profile for globular bushy cells was 28.2 6 6.5 in normal hearing animals. In animals that were deaf for 14 days, there was a significant (P 0.01) 55% decrease to 12.8 6 5.5 ( Fig. 2B and 3) . When expressed as the number of puncta per 10 mm of somatic profile, there was a significant (P 0.01) 49% decrease from 11.4 6 2.6 to 5.9 6 2.5.
Globular bushy cells in PVCN showed a significant (P 0.01) decrease from an average area of 424.5 6 144.8 mm 2 in the CN of normal hearing animals to an average area of 346.3 6 104.1 mm 2 14 days after deafness ( Fig. 2 and 4) .
Radiate cells (type II stellate multipolar cells). Radiate cells were found in the AVCN and PVCN (Fig. 2D ,E) and were glycine immunopositive (normal, n ¼ 4; deaf, n ¼ 4). They were spherical in shape, large (>350 mm 2 ), and received large numbers (>20) of immunopositive axosomatic puncta per somatic profile. The number of axosomatic glycine-immunoreactive puncta per somatic profile for radiate cells was 18.5 6 1.7 in normal hearing animals, whereas in animals that were deaf for 14 days, there was a significant (P 0.01) 61% decrease to 7.3 6 3.2 ( Fig. 2 and 3) . When expressed as the number of puncta per 10 mm of somatic profile, there was the same significant (P 0.01) 61% decrease, now from 6.4 6 1.8 to 2.5 6 1.0. Radiate cells had an average area of 624.1 6 233.2 mm 2 in the CN of normal hearing animals and did not show significant decrease in area after deafening (593.8 6 127.1 mm 2 ; Fig. 2D,E and 4) .
Glycine-immunoreactive type I stellate multipolar cells. Glycine-immunoreactive type I stellate multipolar cells (Fig. 2C,E) were assessed in both the AVCN (normal, n ¼ 72; deaf, n ¼ 47), and PVCN (normal, n ¼ 97; deaf, n ¼ 117). They were small in size (<150 mm 2 ) and received few (<5) immunopositive puncta. In the AVCN, there was not a significant deafness-related decrease in the number of axosomatic glycine-immunoreactive puncta per somatic profile 14 days after deafening. There were 1.8 6 1.9 in normal hearing animals and 1.7 6 1.4 at 14 days after deafening. In PVCN, however, these cells exhibited a 45% decrease from 2.2 6 2.2 in normal hearing animals to 1.2 6 1.5 14 days after deafening (P 0.01; (Fig. 2 and 3 ). Results were similar, when considered as the number of puncta per 10 mm of somatic profile, staying at 1.6 in AVCN and decreasing 34% in PVCN (P 0.01) from 1.8 6 1.8 to 1.2 6 1.7.
Glycine-immunoreactive type I stellate multipolar cells had an average area of 89.6 6 26.0 mm 2 in the AVCN of normal hearing animals. Fourteen days after deafness, there was a significant (P 0.05) decrease to an average area of 78.9 6 26.6 mm 2 . In the PVCN, these cells in were slightly larger 98.1 6 90.2 mm 2 and their decrease after 14 days of deafness to 69.8 6 20.3 mm 2 was significant (P 0.01; Fig. 4) .
Fusiform cells. Fusiform cells in the fusiform layer of the DCN (Fig. 1) were large (>250 mm 2 ), fusiform shaped, and were not immunostained for glycine (normal, n ¼ 71; deaf, n ¼ 93). The number of axosomatic glycine-immunoreactive puncta per somatic profile for fusiform cells was 23.6 6 5.7 in normal hearing animals. After 14 days of deafness, there was a significant (P 0.01) 60% decrease to 9.3 6 4.9 (Fig. 3) . When expressed as the number of puncta per 10 mm of somatic profile, there was a significant (P 0.01) 45% decrease from 7.8 6 5.2 in normal hearing animals to 4.3 6 3.2 in animals 14 days after deafening.
Fusiform cells of the DCN did not show a significant deafness-related change in cell size, with an area of 390.8 6 132.0 mm 2 in normal hearing animals and 406.5 6 132.8 mm 2 in animals 14 days after deafening (Fig. 4) .
Tuberculoventral cells (vertical cells and corn cells). Tuberuculoventral cells were small in size, glycine immunopositive, and in the deep layer of the DCN. The number of glycine immunopositive tuberculoventral cells per 1,000 mm 2 in the deep layer of the DCN decreased 42% from 81 6 21.0 in normal hearing animal to 47 6 19.0 in animals 14 days after deafening (Fig. 5) . The tuberculoventral cells (normal, n ¼ 112; deaf, n ¼ 62) also decreased significantly (P 0.01) in size from an average area of 154.0 6 70.1 mm 2 in normal hearing animals to 108.6 6 47.1 mm 2 in animals 14 days after deafness (Fig. 5) .
DISCUSSION
The results of this study show marked changes in the number of glycine-immunoreactive puncta on spherical bushy, globular bushy, radiate, and fusiform cells 14 days after bilateral deafening. This result is consistent with a loss of inhibition in the CN after deafness and decreases in glycine with age-related hearing loss (Willott et al., 1993; Willott and Turner, 2000) and cochlear ablation (Suneja et al., 1998a,b; Potashner et al., 2000) . The latter studies (Suneja et al., 1998a,b; Potashner et al., 2000) reported decreases in glycine release after cochlear ablation in the AVCN and DCN but not the PVCN.
Our results showed decreases in glycine-immunolabeled puncta on neurons in all three divisions. This may correlate with decreases in the level of glycine within terminals (bringing it below the level of detection), with a physical loss of glycine-containing terminals making somatic contact, or some combination of the two. Ultrastructural studies (Bilak et al., 1997; Bendiske and Morest, 2004; Kim et al., 2004a,b,c; Subramani and Morest, 2004) and studies using synaptophysin to label terminals (Muly et al., 2002) demonstrate that there can be marked changes in terminals and synapses in the CN after deafening from noise overstimulation. Moreover, decreases in glycine levels, if they do occur, may not always correlate with decreases in release and the specific mechanisms that regulate release. Indeed deafness-related changes in potential regulators of transmitter release have been demonstrated recently in the auditory brainstem Zhang et al., 2003) . Immunocytochemical studies at the ultrastructural level after cochlear ablation would therefore be valuable.
There were many glycine-immunoreactive puncta in the neuropil, in addition to those apposing neuronal somata that were assessed in the current study. The immunolabeled puncta in neuropil likely correspond to axodendritic terminals containing glycine. Because we could not easily attribute these puncta to a specific neuronal type, we did not assess their number or determine if that changed after deafening. Qualitatively, however, there did seem to be a decrease in their number and the intensity of their immunostaining, suggesting that they may change as well, in a similar fashion to those on the neuronal somata.
CN neurons receive glycinergic input from multiple sources, including the DCN (Wickesberg et al., 1991 (Wickesberg et al., , 1994 Zhang and Oertel, 1993) , the contralateral VCN (Wenthold, 1987; Babalian et al., 2002) , and the superior olivary complex (e.g., Ostapoff et al., 1997) . It is interesting to consider whether the decrease in glycine immunostained puncta on CN neurons reflects the loss of an input from a single source or a decrease across multiple inputs. The decrease in glycine-immunostained tuberculoventral cells suggests that they may contribute to the loss of glycine-immunostained puncta in the VCN. It will be valuable in future studies to combine tract tracing and immunocytochemistry to identify further the glycine inputs that are most affected.
Spherical bushy, globular bushy, glycine-immunoreactive type I stellate multipolar and tuberculoventral cells all showed decreases in size after deafening, consistent with previous studies from our lab and others (Lesperance et al., 1995; Pasic et al., 1994; Pasic and Rubel 1991) . The lack of a cell size change for fusiform cells may be related to their excitatory input from granule cells of the shell region, which may be less affected by the deafening. Another interesting question to consider is why radiate cells did not show a cell size decrease and suggests they might also have an alternate source of excitatory input.
With the results of Potashner et al. (2000) and Suneja et al. (1998a,b) showing decreases in strychnine binding in the AVCN and PVCN after cochlear ablation, it would be interesting in future studies to compare and contrast changes in glycine with changes in glycine receptors as well as comparing and contrasting changes in GABA and GABA receptors. Error bars represent 61 standard deviation. *P 0.05.
